The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
RNS it says----"Futura has retained specialised corporate advisers with international experience to facilitate active commercial discussions with potential licensing and marketing partners and is actively pursuing discussions".
My view is that a deal will be struck with a potential partner as detailed and they will provide the cash for the final US test--lets see !
Looks to me that with the high share volume over the last two days some institution is is acquiring more shares. Wouldn't be surprised to see a shareholding declared soon-or maybe a deal being announced ? If so this will look cheap.
Well didn't really want a drop in share price but I think this is really good news for the future as shouldn't need to raise any more funds. The investors who have bought into the placing obviously think the share price will rise and it will, probably much higher than it has been before.
Also I expect the name of the global company that they recently obtained a contract with will be revealed shortly to shoot the share price back up again.
Up 10.9% at close and only just over 2 million traded. This is going to go up all the way to the update which is due in a couple of weeks and then it will really start moving. Could easily be £1.00 by Xmas.
The contracts they have gained are coming in at regular intervals and there are more are in the pipeline I'll bet.
The new team have done very well to date but I thing that we are only at the beginning of their ambitions.
In a few months time today's price will seem a real bargain as we near 10p a share as Zak says.
I can't wait to find out who this Global company is--If its a big one the shares will really rocket. Hold onto your hats.
3.50 ask level 2
Starting to move up again level 2-have sellers finished?
Well they have made a profit which is a first-so results not that bad at all.
Its a pity that Sierra Leonne was closed down during the period otherwise profit would have been higher.
You can see that if one or two more deals were won and contributed to the bottom line Westminster could really become a winner.
No mention of possibilities in the RNS which is unusual ,is that just to keep things quiet so that they can purchase some shares or is something in the offing that can't be disclosed yet-we shall see no doubt.
My view-now in profit-hold tight-could be a big winner-lets see!
RNS says "Futura has now appointed specialised corporate advisers with international experience to facilitate commercial discussions with potential licensing and marketing partners."
Seems to me that all things are headed in the right directions here and what I expect is that a licencing deal will be struck in the next couple of months that is subject to full EU approval.
This will provide the funds for the full test in the US and no doubt contain conditions that the licencee can extend the licence into the USA provided the trial there is a success.
So I do not expect further fundraising-the next news being a licence agreement and a big jump in share price.we shall see
With this latest order it takes the forward order book to £29.7 million which is brilliant and they are trading at a profit all looks extremely good for the future and share price miles behing where it should be and due a rerating when investors cotton on.
Yep nows the time to get aboard-way too cheap at the moment.
The Guardian 24 jULY
Mark Brewer, an analyst at FinnCap, Synairgen’s house broker, said: “Valuing the Covid-19 opportunity is nigh on impossible; however, we upgrade our target price to 360p but recognise this could go substantially higher, based on upcoming discussions with regulators,”
What can be expected next.
Clearly they will need cash to do the US trial that the FDA have requested, but do they need it now.
My opinion is that they will wait to get the EU approval due out in the next few months first.
When they get this the share price will rocket and they will get a deal with one of the Pharma companies for Europe.
This deal will probably include the Pharma paying for the US trial with rights to the US market as well if the US trial goes ok .
So possibly no more fund raising would be required in this case.
In fact with the EU results being not that far way someone could come in at any time to scoop up a deal with FUM at any time.
Could be next week or next month-but at todays price the rise could be as much as one of the vavoured covid stocks.
Lets see. I'm now in with a 100,000 plus shares and betting ona big win here.
The webinar did not set the world alight however the future here could be more exciting than investors give credit for.
They are annually gaining streams of constant income, gaining new alliances like saudi arabia, getting more professional in communicating (website upgrade) and selling more kit. Through all this they are becoming more well known throught their markets. In addition to this they are gaining a reputation for excellence of operation which is no small thing.
Whilst we see and hear Fowler most of the time they must have some very good employees that we are unaware of.
All that is needed is for them to accelerate the gaining of regular contracts. Just one more good one would double the share price. Whilst the share is obviously a bit speculative my view is that it has a very big potential. If more deals come in everone will want to get on board-so if you want to be part of it take a stake today.
What must be going on at Synairgen at the moment in the office withloads of phone calls,video conferencing,interviews,deals offered etc etc, information being provided, full trial reviews being done etc etc ---it must be hectic.
It expect it will be a few days to get through all this stuff before we get more news-BUT THEN !
The share price rise could be amazing- this has got to be theshare to have.